Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on HCP

Share:
Related HCP
Healthcare REITs Down On Brookdale, HCP Guidance
Worst Performing Industries For February 9, 2016
Healthcare REITs fall sharply after HCP/Brookdale/MPW issue light guidance (Seeking Alpha)

In a report published Wednesday, Jefferies & Company reiterated its Hold rating on HCP (NYSE: HCP), and raised its price target from $42.00 to $45.00.

Jefferies noted, “On 10/16/2012, HCP announced that it will acquire 133 senior housing communities for $1.73B from a joint venture between Emeritus (ESC, $22.93, NC) and an affiliate of Blackstone (BX, $15.36, Buy). While the 6.1% initial (i.e first-year) lease yield may raise some eyebrows, we view the deal as a positive given it's accretive nature to earnings, attractive contractual step-ups, and downside protection from the triple-net leases.”

HCP closed on Tuesday at $45.92.

Latest Ratings for HCP

DateFirmActionFromTo
Jan 2016JefferiesDowngradesHoldUnderperform
Jan 2016BarclaysDowngradesEqual-weightUnderweight
Jan 2016Argus ResearchDowngradesBuyHold

View More Analyst Ratings for HCP
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCP)

View Comments and Join the Discussion!

Get Benzinga's Newsletters